Precigen Inc (PGEN)
Precigen stock today
Precigen closed at $6.94 on October 30, 2026, up 4.52% on the day. Over the past year it returned +71.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.47 billion.
| Period | PGEN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -18.9% | -0.9% |
| 3 months | +16.8% | +2.1% |
| Year to date | +66.0% | +11.7% |
| 1 year | +71.4% | +12.4% |
| 3 years | +548.6% | +88.5% |
| 5 years | +43.7% | +76.0% |
Key statistics
- Market value
- $2.47B
- Forward P/E
- 16.6
- Price / sales
- 28.9
- 52-week range
- $3.10 to $8.56
- Next report
- Nov 4, 2026
About Precigen
Develops biotechnology and cell-based therapeutics.
Sector: Health Care
More on Precigen
- Financials: revenue, earnings and segmentsRevenue +147% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $272.71 today
No forecast, no recommendation. This page describes Precigen Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.